期刊文献+

38例儿童万古霉素不良反应的Pareto最优分析 被引量:4

Pareto Optimal Analysis of 38 Cases of Adverse Drug Reactions Induced by Vancomycin
下载PDF
导出
摘要 目的:分析儿童发生万古霉素不良反应(ADR)的一般特点及规律,为合理用药提供参考。方法:用Pareto最优分析,对2009-2015年湖南省儿童医院上报国家药品不良反应监测系统的38例万古霉素ADR报告进行整理,从患儿年龄、性别、用药后ADR发生时间、合并用药、ADR累及器官/系统及临床表现等方面进行统计分析。结果:发生万古霉素ADR的患儿中,男性高于女性(73.7%vs 26.3%);患儿年龄集中在1个月-2岁(79.0%);ADR发生时间主要在用药60 min以内(50.0%)和用药7 d后(21.1%);有27例(71.1%)使用3种及以上药物联合治疗;ADR主要临床表现为过敏反应(64.6%),主要累及皮肤及其附件。结论:临床医师、药师应了解儿童万古霉素ADR的特点和规律,加强其应用监测,以减少ADR的发生。 Objective: To study characteristics and rules of adverse drug reactions(ADR) induced by vancomycin,and provide references for clinical rational use of the drugs.Methods: The Pareto optimal analysis was adopted to analyze 38 cases of ADRs which were reported from Hunan Children's Hospital to the National Adverse Drug Reaction 2009 to 2015 in respect of the children's age,sex,time of occurrence of ADRs,combined medication,ADR involving organ systems and clinical manifestations.Results: ADRs induced by vancomycin in children,the proportion of boys was significantly higher than that of girls,1 mouth to 2 years old(79.0%)was the major age,most cases occurred in 60 minutes(50.0%) and 7 days(21.1%) after the drug use.Twenty-seven children(71.1%) were treated with three kinds of drugs or more.The clinical manifestations of ADR were allergic reaction(64.6%).Conclusion: Clinical doctors and pharmacists should understand the pattern and characteristics of ADRs induced by vancomycin,and strengthen monitoring of its use to reduce occurrence of ADRs.
机构地区 湖南省儿童医院
出处 《儿科药学杂志》 CAS 2016年第12期44-46,共3页 Journal of Pediatric Pharmacy
关键词 万古霉素 药物不良反应 PARETO最优 vancomycin adverse drug reactions Pareto optimal
  • 相关文献

参考文献4

二级参考文献24

  • 1杨进波,赵明.种族差异对药代动力学影响的研究进展[J].中国临床药理学杂志,2005,21(3):225-228. 被引量:16
  • 2Wang G, Hindler JF, Ward KW, et al. Increased van- comycin MICs for Staphylococcus aureus clinical iso- lates from a university hospital during a 5-year period [J]. J Clin Microbiol, 2006, 44(11): 3883-6. 被引量:1
  • 3Rybak M, Lomaestro B, Rotschafer JC, et al. Thera- peutic monitoring of vancomycin in adult patients: a consensus review of the American society of health- system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharma- cists[J]. Am J Health Syst Pharm, 2009, 66(1): $2-98. 被引量:1
  • 4Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary[J]. Clin Infect Dis, 20ll, 52(3): 285-92. 被引量:1
  • 5Niederman MS, Craven DE, Bonten M J, et al. Guide- lines for the management of adults with hospital-ac- quired, ventilator-associated, and healthcare-associated pneumonia [J]. Am J Respir Crit Care Med, 2005. 171 (4): 388-416. 被引量:1
  • 6Clemens EC, Chan JD, Lynch JB, et al. Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistantS,qdtylococcmre,s bacteremia [J]. Diagtz Microbiol, 2011. 71(4): 408-14. 被引量:1
  • 7Chan JD, Pharn TN, Wong J, et a1. Clinical outcomes of linezolid vs vancomycin in methicillin =resistant Staphylococcus aureus ventilator -associated pneumonia: retrospective analysis [J].J Intensive Care Med, 2011, 26(6): 385-91. 被引量:1
  • 8Kullar R, Davis SL, Levine DP, et a1. Impact of van-comycin exposure on outcomes in patients with methi-cillin =resistant S/,apillococcus aureus bacteremia: sup-port for consensus guidel i nes suggested targets [J]. Clin. Infect Dis, 2011, 52(8): 975-81. 被引量:1
  • 9Roberts .lA, Taccone FS, Udy AA, et al. Vancomycin dosing in critically ill patients: robust methods for im-proved continuous-infusion regimens [J]. A ruimicrob A-gents Chemother, 2011, 55(6): 2704-9. 被引量:1
  • 10Spa pen HD, van Doorn KJ, Diltoer M, et al. Retro-spective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients[J]. Ann lntensiue Care, 2011, 1(1): 26. 被引量:1

共引文献57

同被引文献32

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部